These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 6087329)

  • 21. Deletion of 19 base pairs in intron 13 of the gene for the pro alpha 2(I) chain of type-I procollagen (COL1A2) causes exon skipping in a proband with type-I osteogenesis imperfecta.
    Zhuang J; Tromp G; Kuivaniemi H; Nakayasu K; Prockop DJ
    Hum Genet; 1993 Apr; 91(3):210-6. PubMed ID: 7916744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substitution of cysteine for glycine-alpha 1-691 in the pro alpha 1(I) chain of type I procollagen in a proband with lethal osteogenesis imperfecta destabilizes the triple helix at a site C-terminal to the substitution.
    Steinmann B; Westerhausen A; Constantinou CD; Superti-Furga A; Prockop DJ
    Biochem J; 1991 Nov; 279 ( Pt 3)(Pt 3):747-52. PubMed ID: 1953667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Localization of a structural defect in type I procollagen in a patient affected with the severe non-lethal form of Osteogenesis imperfecta.
    Dyne K; Cetta G; Tenni R; Rossi A; Finardi E; Brunelli PC; Castellani AA
    Ital J Biochem; 1987; 36(4):256-66. PubMed ID: 3429209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of a shortened pro-alpha 2(I) chain and decreased synthesis of pro-alpha 2(I) chains in a proband with osteogenesis imperfecta.
    de Wet WJ; Pihlajaniemi T; Myers J; Kelly TE; Prockop DJ
    J Biol Chem; 1983 Jun; 258(12):7721-8. PubMed ID: 6863261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substitution of serine for alpha 1(I)-glycine 844 in a severe variant of osteogenesis imperfecta minimally destabilizes the triple helix of type I procollagen. The effects of glycine substitutions on thermal stability are either position of amino acid specific.
    Pack M; Constantinou CD; Kalia K; Nielsen KB; Prockop DJ
    J Biol Chem; 1989 Nov; 264(33):19694-9. PubMed ID: 2511192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Presence of translatable mRNA for pro alpha 2(I) chains in fibroblasts from a patient with osteogenesis imperfecta whose type I collagen does not contain alpha 2(I) chains.
    Chu ML; Rowe D; Nicholls AC; Pope FM; Prockop DJ
    Coll Relat Res; 1984 Oct; 4(5):389-94. PubMed ID: 6210173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteogenesis imperfecta type IV: evidence of abnormal triple helical structure of type I collagen.
    Wenstrup RJ; Hunter AG; Byers PH
    Hum Genet; 1986 Sep; 74(1):47-53. PubMed ID: 3759085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 19-base pair deletion in the pro-alpha 2(I) gene of type I procollagen that causes in-frame RNA splicing from exon 10 to exon 12 in a proband with atypical osteogenesis imperfecta and in his asymptomatic mother.
    Kuivaniemi H; Sabol C; Tromp G; Sippola-Thiele M; Prockop DJ
    J Biol Chem; 1988 Aug; 263(23):11407-13. PubMed ID: 3403536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A lethal variant of osteogenesis imperfecta has a single base mutation that substitutes cysteine for glycine 904 of the alpha 1(I) chain of type I procollagen. The asymptomatic mother has an unidentified mutation producing an overmodified and unstable type I procollagen.
    Constantinou CD; Nielsen KB; Prockop DJ
    J Clin Invest; 1989 Feb; 83(2):574-84. PubMed ID: 2913053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BiP binds type I procollagen pro alpha chains with mutations in the carboxyl-terminal propeptide synthesized by cells from patients with osteogenesis imperfecta.
    Chessler SD; Byers PH
    J Biol Chem; 1993 Aug; 268(24):18226-33. PubMed ID: 8349698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of R-loop mapping for the assessment of human collagen mutations.
    de Wett W; Sippola M; Tromp G; Prockop D; Chu ML; Ramirez F
    J Biol Chem; 1986 Mar; 261(8):3857-62. PubMed ID: 3949794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The substitution of arginine for glycine 85 of the alpha 1(I) procollagen chain results in mild osteogenesis imperfecta. The mutation provides direct evidence for three discrete domains of cooperative melting of intact type I collagen.
    Deak SB; Scholz PM; Amenta PS; Constantinou CD; Levi-Minzi SA; Gonzalez-Lavin L; Mackenzie JW
    J Biol Chem; 1991 Nov; 266(32):21827-32. PubMed ID: 1718984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Osteogenesis imperfecta type IV. Biochemical confirmation of genetic linkage to the pro alpha 2(I) gene of type I collagen.
    Wenstrup RJ; Tsipouras P; Byers PH
    J Clin Invest; 1986 Dec; 78(6):1449-55. PubMed ID: 3782466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The mRNAs for the pro-alpha 1(I) and pro-alpha 2(I) chains of type I procollagen are translated at the same rate in normal human fibroblasts and in fibroblasts from two variants of osteogenesis imperfecta with altered steady state ratios of the two mRNAs.
    de Wet WJ; Chu ML; Prockop DJ
    J Biol Chem; 1983 Dec; 258(23):14385-9. PubMed ID: 6689020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transgenic mice that express a mini-gene version of the human gene for type I procollagen (COL1A1) develop a phenotype resembling a lethal form of osteogenesis imperfecta.
    Khillan JS; Olsen AS; Kontusaari S; Sokolov B; Prockop DJ
    J Biol Chem; 1991 Dec; 266(34):23373-9. PubMed ID: 1744131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct sequencing of PCR products derived from cDNAs for the pro alpha 1 and pro alpha 2 chains of type I procollagen as a screening method to detect mutations in patients with osteogenesis imperfecta.
    Zhuang J; Tromp G; Kuivaniemi H; Castells S; Bugge M; Prockop DJ
    Hum Mutat; 1996; 7(2):89-99. PubMed ID: 8829649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frameshift mutation near the 3' end of the COL1A1 gene of type I collagen predicts an elongated Pro alpha 1(I) chain and results in osteogenesis imperfecta type I.
    Willing MC; Cohn DH; Byers PH
    J Clin Invest; 1990 Jan; 85(1):282-90. PubMed ID: 2295701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a mutation in the COL1A2 gene of type I collagen. The mosaic parent exhibits phenotypic features of a mild form of the disease.
    Edwards MJ; Wenstrup RJ; Byers PH; Cohn DH
    Hum Mutat; 1992; 1(1):47-54. PubMed ID: 1301191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A heterozygous defect for structurally altered pro-alpha 2 chain of type I procollagen in a mild variant of osteogenesis imperfecta. The altered structure decreases the thermal stability of procollagen and makes it resistant to procollagen N-proteinase.
    Sippola M; Kaffe S; Prockop DJ
    J Biol Chem; 1984 Nov; 259(22):14094-100. PubMed ID: 6438090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Internal deletion in a collagen gene in a perinatal lethal form of osteogenesis imperfecta.
    Chu ML; Williams CJ; Pepe G; Hirsch JL; Prockop DJ; Ramirez F
    Nature; 1983 Jul 7-13; 304(5921):78-80. PubMed ID: 6191221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.